RxDoctor Payments Data

Kelly Garcia, MD

Family Medicine · Clyde, NCNPI 1043625965

Payments from drug & device makers

$530in general payments, 2019–2025

Across 25 payments — averaging $21.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tandem Diabetes Care, Inc.$180
  • Indivior Inc.$161
  • Averitas Pharma Inc.$30
  • Abbott$30
  • Exact Sciences$30
  • Lilly USA, LLC$26
  • plus $74 from 5 others

What the payments were for

  • Food & beverage$530100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$530 in reported general payments places this provider in the 60th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,741
Medicare patients
63
Services billed
147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin111$167,566
TrulicityDulaglutide76$146,319
OzempicSemaglutide58$83,861
JanuviaSitagliptin Phosphate21$34,919
FarxigaDapagliflozin Propanediol29$34,765
EliquisApixaban30$32,634
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$31,476
XareltoRivaroxaban28$28,252
MounjaroTirzepatide19$28,044
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr25$25,053
Breo ElliptaFluticasone/Vilanterol25$15,888
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$13,480
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/718$13,124
SymbicortBudesonide/Formoterol Fumarate28$12,922
Lantus SolostarInsulin Glargine,hum.Rec.Anlog55$10,825

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$26$174,36395 claims
Novo NordiskOzempic$15$83,86158 claims
PfizerEliquis, Premarin$17$38,52343 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Clyde

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →